Temporary Treatment With AT1 Receptor Blocker, Valsartan, From Early Stage of Hypertension Prevented Vascular Remodeling
Author:
Publisher
Oxford University Press (OUP)
Subject
Internal Medicine
Link
http://academic.oup.com/ajh/article-pdf/24/5/550/17459887/24_5_550.pdf
Reference24 articles.
1. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol;LIFE Study Group;Lancet,2002
2. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study;Jikei Heart Study group;Lancet,2007
3. Is prehypertension a risk factor for cardiovascular diseases?;Stroke,2005
4. Prehypertension and cardiovascular disease risk in the Women's Health Initiative;Women's Health Initiative Investigators;Circulation,2007
5. Feasibility of treating prehypertension with an angiotensin-receptor blocker;Trial of Preventing Hypertension (TROPHY) Study Investigators;N Engl J Med,2006
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Aerobic Physical Exercise is Essential for Cardiac Autonomic Regulation in Hypertensive Patients Undergoing Chronic Treatment with Renin- Angiotensin System Inhibitors;Current Vascular Pharmacology;2023-07
2. Experimental models for identifying target events in vascular injury;Endothelial Signaling in Vascular Dysfunction and Disease;2021
3. Impact of diabetes, angiotensin‐converting enzyme inhibitor or angiotensin II receptor blocker use, and statin use on presentation and outcomes in patients with giant cell arteritis;International Journal of Rheumatic Diseases;2020-08-10
4. Physical training associated with Enalapril but not to Losartan, results in better cardiovascular autonomic effects;Autonomic Neuroscience;2017-03
5. Angiotensin II type 1 receptor antagonists in animal models of vascular, cardiac, metabolic and renal disease;Pharmacology & Therapeutics;2016-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3